Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) - Total Liabilities

Latest as of March 2026: CN¥47.87 Billion CNY ≈ $7.00 Billion USD

Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has total liabilities worth CN¥47.87 Billion CNY (≈ $7.00 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 600332 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Total Liabilities Trend (1997–2025)

This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 600332 asset base.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors by Total Liabilities

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
RAMSAY HLTH.CARE ADR/025 F:RMY0	Germany	€16.77 Billion
Companhia Energética de Minas Gerais F:CID	Germany	€38.45 Billion
Archer Aviation Inc NYSE:ACHR	USA	$298.70 Million
HOSHIZAKIL UNSP.ADR/025 F:HS00	Germany	€161.73 Billion
Ero Copper Corp TO:ERO	Canada	CA$937.25 Million
Shandong Xinchao Energy Co Ltd SHG:600777	China	CN¥11.77 Billion
Shapir Engineering Industry TA:SPEN	Israel	ILA12.93 Billion

Liability Composition Analysis (1997–2025)

This chart breaks down Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Guangzhou Baiyunshan Pharmaceutical Hold (600332) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (1997–2025)

The table below shows the annual total liabilities of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 1997 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥43.39 Billion ≈ $6.35 Billion	-1.20%
2024-12-31	CN¥43.91 Billion ≈ $6.43 Billion	+4.78%
2023-12-31	CN¥41.91 Billion ≈ $6.13 Billion	+2.15%
2022-12-31	CN¥41.03 Billion ≈ $6.00 Billion	+17.93%
2021-12-31	CN¥34.79 Billion ≈ $5.09 Billion	+10.26%
2020-12-31	CN¥31.55 Billion ≈ $4.62 Billion	+2.11%
2019-12-31	CN¥30.90 Billion ≈ $4.52 Billion	+9.05%
2018-12-31	CN¥28.34 Billion ≈ $4.15 Billion	+213.08%
2017-12-31	CN¥9.05 Billion ≈ $1.32 Billion	+9.80%
2016-12-31	CN¥8.24 Billion ≈ $1.21 Billion	+14.70%
2015-12-31	CN¥7.19 Billion ≈ $1.05 Billion	+14.95%
2014-12-31	CN¥6.25 Billion ≈ $914.84 Million	+19.61%
2013-12-31	CN¥5.23 Billion ≈ $764.86 Million	+159.91%
2012-12-31	CN¥2.01 Billion ≈ $294.28 Million	+110.34%
2011-12-31	CN¥956.09 Million ≈ $139.91 Million	+14.50%
2010-12-31	CN¥835.05 Million ≈ $122.19 Million	+1.72%
2009-12-31	CN¥820.92 Million ≈ $120.13 Million	-9.39%
2008-12-31	CN¥905.99 Million ≈ $132.58 Million	-68.90%
2007-12-31	CN¥2.91 Billion ≈ $426.22 Million	+18.63%
2006-12-31	CN¥2.46 Billion ≈ $359.28 Million	+7.16%
2005-12-31	CN¥2.29 Billion ≈ $335.27 Million	-10.02%
2004-12-31	CN¥2.55 Billion ≈ $372.62 Million	+20.63%
2003-12-31	CN¥2.11 Billion ≈ $308.88 Million	+20.60%
2002-12-31	CN¥1.75 Billion ≈ $256.13 Million	+23.83%
2001-12-31	CN¥1.41 Billion ≈ $206.85 Million	-9.71%
2000-12-31	CN¥1.57 Billion ≈ $229.10 Million	+2.80%
1999-12-31	CN¥1.52 Billion ≈ $222.87 Million	-4.66%
1998-12-31	CN¥1.60 Billion ≈ $233.77 Million	-6.08%
1997-12-31	CN¥1.70 Billion ≈ $248.91 Million	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

SHG:600332 China Medical Distribution

Market Cap

$4.00 Billion

CN¥27.34 Billion CNY

Market Cap Rank

#4091 Global

#600 in China

Share Price

CN¥19.45

Change (1 day)

+0.31%

52-Week Range

CN¥19.39 - CN¥27.37

All Time High

CN¥41.57